{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:27:11Z","timestamp":1792506431352,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Krebsforschungszentrum (DKFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) exhibits pronounced inter- and intratumoral heterogeneity, emphasizing the need for preclinical models that accurately capture its molecular and histological diversity. Patient-derived organoids (PDOs) represent valuable ex vivo systems to model CRC, yet whether they can preserve subtype-specific features and maintain fidelity upon in vivo transplantation remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We established a biobank of PDOs from both treatment-na\u00efve and neoadjuvant-treated CRC patients, encompassing the major histological subtypes \u2013 micropapillary, medullary, serrated, mucinous, and adenocarcinoma not otherwise specified (NOS). PDOs were comprehensively characterized by histomorphological, genomic, and transcriptomic analyses. To assess in vivo fidelity, PDOs were orthotopically transplanted into immunodeficient mice to generate patient-derived organoid xenografts (PDOXs). PDOX-derived tumors and organoids were analyzed to evaluate the preservation of histological and molecular traits, as well as therapy responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PDOs displayed distinct, subtype-specific morphologies and growth patterns that closely paralleled their respective patient tumor histologies. Orthotopic PDOXs recapitulated the histological architecture, gene expression profiles, and signaling pathway activation of the original tumors. PDOX-derived organoids retained these subtype-specific morphologies, molecular features, and exhibited similar responses to FOLFOX treatment as their corresponding PDOs, confirming both molecular and functional stability of the organoid-xenograft cycle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study establishes orthotopic transplantation of CRC PDOs as a robust and predictive preclinical model that captures the full spectrum of CRC heterogeneity. The model preserves histological and molecular subtype fidelity across in vitro and in vivo contexts and enables functional assessment of therapy response. By bridging patient-derived tumor biology with translational modeling, this platform provides a valuable resource for dissecting CRC pathogenesis and advancing patient-tailored precision oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03666-x","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:37:19Z","timestamp":1771997839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A translational colorectal cancer organoid biobank mirrors patients\u2019 tumor histology, molecular profiles, and treatment responses"],"prefix":"10.1186","volume":"45","author":[{"given":"Moritz","family":"Jesinghaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Gomes","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Enrico","family":"Zaurito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anantharamanan","family":"Rajamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"de Andrade Kr\u00e4tzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bodenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Guillemant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junika","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"\u00d6llinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Shakhtour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Klare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Peter","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Foersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Pfarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Saur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-4790","authenticated-orcid":false,"given":"Markus","family":"Tschurtschenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"2","key":"3666_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc.2016.126","volume":"17","author":"R Dienstmann","year":"2017","unstructured":"Dienstmann R, et al. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer. 2017;17(2):79\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"10207","key":"3666_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, et al. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380.","journal-title":"Lancet"},{"issue":"10","key":"3666_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883\u201392.","journal-title":"N Engl J Med"},{"issue":"2","key":"3666_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138.","journal-title":"Histopathology"},{"key":"3666_CR5","volume-title":"WHO Classification of Tumours of the Digestive System Tumours","author":"D Lokuhetty","year":"2019","unstructured":"Lokuhetty D, W.H. Organization, I.A.f.R.o. Cancer. WHO Classification of Tumours of the Digestive System Tumours. IARC Press; 2019."},{"issue":"7","key":"3666_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/PAS.0000000000001692","volume":"45","author":"M Jesinghaus","year":"2021","unstructured":"Jesinghaus M, et al. Morphology matters: A critical reappraisal of the clinical relevance of morphologic criteria from the 2019 WHO classification in a large colorectal cancer cohort comprising 1004 cases. Am J Surg Pathol. 2021;45(7):969\u201378.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3666_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","volume":"18","author":"A Lugli","year":"2021","unstructured":"Lugli A, et al. Tumour budding in solid cancers. Nat Rev Clin Oncol. 2021;18(2):101\u201315.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"3666_CR8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","volume":"30","author":"A Lugli","year":"2017","unstructured":"Lugli A, et al. Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016. Mod Pathol. 2017;30(9):1299\u2013311.","journal-title":"Mod Pathol"},{"issue":"7407","key":"3666_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"N Cancer Genome Atlas","year":"2012","unstructured":"Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330\u20137.","journal-title":"Nature"},{"issue":"11","key":"3666_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136.","journal-title":"Nat Med"},{"key":"3666_CR11","doi-asserted-by":"publisher","first-page":"15107","DOI":"10.1038\/ncomms15107","volume":"8","author":"C Isella","year":"2017","unstructured":"Isella C, et al. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer. Nat Commun. 2017;8:15107.","journal-title":"Nat Commun"},{"issue":"10","key":"3666_CR12","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s12276-021-00654-3","volume":"53","author":"T Seidlitz","year":"2021","unstructured":"Seidlitz T, Stange DE. Gastrointestinal cancer organoids-applications in basic and translational cancer research. Exp Mol Med. 2021;53(10):1459\u201370.","journal-title":"Exp Mol Med"},{"issue":"2","key":"3666_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41563-020-0754-0","volume":"20","author":"M Fujii","year":"2021","unstructured":"Fujii M, Sato T. Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases. Nat Mater. 2021;20(2):156\u201369.","journal-title":"Nat Mater"},{"issue":"1","key":"3666_CR14","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1038\/s41467-024-47547-3","volume":"15","author":"RE Hynds","year":"2024","unstructured":"Hynds RE, et al. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. Nat Commun. 2024;15(1):4653.","journal-title":"Nat Commun"},{"issue":"7","key":"3666_CR15","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41591-021-01398-3","volume":"27","author":"P Voabil","year":"2021","unstructured":"Voabil P, et al. An ex vivo tumor fragment platform to dissect response to PD-1 Blockade in cancer. Nat Med. 2021;27(7):1250\u201361.","journal-title":"Nat Med"},{"issue":"1","key":"3666_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53163-y","volume":"15","author":"U Perron","year":"2024","unstructured":"Perron U, et al. Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts. Nat Commun. 2024;15(1):9139.","journal-title":"Nat Commun"},{"issue":"18","key":"3666_CR17","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1158\/0008-5472.CAN-11-1245","volume":"71","author":"M Squatrito","year":"2011","unstructured":"Squatrito M, Holland EC. DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance. Cancer Res. 2011;71(18):5945\u20139.","journal-title":"Cancer Res"},{"issue":"11","key":"3666_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/ng.3967","volume":"49","author":"U Ben-David","year":"2017","unstructured":"Ben-David U, et al. Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet. 2017;49(11):1567\u201375.","journal-title":"Nat Genet"},{"issue":"6","key":"3666_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","volume":"18","author":"M Fujii","year":"2016","unstructured":"Fujii M, et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell. 2016;18(6):827\u201338.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"3666_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/nm.2470","volume":"17","author":"P Jung","year":"2011","unstructured":"Jung P, et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med. 2011;17(10):1225\u20137.","journal-title":"Nat Med"},{"issue":"7702","key":"3666_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","volume":"556","author":"SF Roerink","year":"2018","unstructured":"Roerink SF, et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature. 2018;556(7702):457\u201362.","journal-title":"Nature"},{"issue":"4","key":"3666_CR22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering M, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161(4):933\u201345.","journal-title":"Cell"},{"issue":"1","key":"3666_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Yao Y, et al. Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer. Cell Stem Cell. 2020;26(1):17-26 e6.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"3666_CR24","doi-asserted-by":"publisher","first-page":"E2357","DOI":"10.1073\/pnas.1701219114","volume":"114","author":"A Fumagalli","year":"2017","unstructured":"Fumagalli A, et al. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A. 2017;114(12):E2357\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3666_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nm.3802","volume":"21","author":"M Matano","year":"2015","unstructured":"Matano M, et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat Med. 2015;21(3):256\u201362.","journal-title":"Nat Med"},{"issue":"7","key":"3666_CR26","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018;175(7):1972\u2013e198816.","journal-title":"Cell"},{"issue":"6","key":"3666_CR27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell. 2018;174(6):1586-1598 e12.","journal-title":"Cell"},{"issue":"10","key":"3666_CR28","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","volume":"13","author":"HF Farin","year":"2023","unstructured":"Farin HF, et al. Colorectal cancer Organoid-Stroma biobank allows Subtype-Specific assessment of individualized therapy responses. Cancer Discov. 2023;13(10):2192\u2013211.","journal-title":"Cancer Discov"},{"issue":"12","key":"3666_CR29","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23(12):1424\u201335.","journal-title":"Nat Med"},{"issue":"6","key":"3666_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","volume":"23","author":"HHN Yan","year":"2018","unstructured":"Yan HHN, et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell. 2018;23(6):882-897 e11.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"3666_CR31","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jgh.15818","volume":"37","author":"RM Engel","year":"2022","unstructured":"Engel RM, et al. Modeling colorectal cancer: a bio-resource of 50 patient-derived organoid lines. J Gastroenterol Hepatol. 2022;37(5):898\u2013907.","journal-title":"J Gastroenterol Hepatol"},{"key":"3666_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay2574","author":"SN Ooft","year":"2019","unstructured":"Ooft SN, et al. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Sci Transl Med. 2019;11(513). https:\/\/doi.org\/10.1126\/scitranslmed.aay2574.","journal-title":"Sci Transl Med"},{"issue":"6378","key":"3666_CR33","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, et al. Patient-derived organoids model treatment response of metastatic Gastrointestinal cancers. Science. 2018;359(6378):920\u20136.","journal-title":"Science"},{"issue":"3","key":"3666_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ijc.34302","volume":"152","author":"T Lv","year":"2023","unstructured":"Lv T, et al. Patient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Int J Cancer. 2023;152(3):524\u201335.","journal-title":"Int J Cancer"},{"issue":"31","key":"3666_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204097","volume":"9","author":"S Mo","year":"2022","unstructured":"Mo S, et al. Patient-derived organoids from colorectal cancer with paired liver metastasis reveal tumor heterogeneity and predict response to chemotherapy. Adv Sci. 2022;9(31):e2204097.","journal-title":"Adv Sci"},{"issue":"3","key":"3666_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101198","volume":"8","author":"G Martini","year":"2023","unstructured":"Martini G, et al. Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer. ESMO Open. 2023;8(3):101198.","journal-title":"ESMO Open"},{"key":"3666_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153760","author":"M Park","year":"2021","unstructured":"Park M, et al. A patient-derived organoid-based radiosensitivity model for the prediction of radiation responses in patients with rectal cancer. Cancers (Basel). 2021;13(15). https:\/\/doi.org\/10.3390\/cancers13153760.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"3666_CR38","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","volume":"56","author":"L Thorel","year":"2024","unstructured":"Thorel L, et al. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Exp Mol Med. 2024;56(7):1531\u201351.","journal-title":"Exp Mol Med"},{"issue":"6","key":"3666_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nbt.3836","volume":"35","author":"J Roper","year":"2017","unstructured":"Roper J, et al. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol. 2017;35(6):569\u201376.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"3666_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100353","volume":"2","author":"JK Kim","year":"2022","unstructured":"Kim JK, et al. An immunocompetent rectal cancer model to study radiation therapy. Cell Rep Methods. 2022;2(12):100353.","journal-title":"Cell Rep Methods"},{"issue":"4","key":"3666_CR41","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ijrobp.2023.10.008","volume":"118","author":"H Felchle","year":"2024","unstructured":"Felchle H, et al. Novel tumor organoid-based mouse model to study image guided radiation therapy of rectal cancer after noninvasive and precise endoscopic implantation. Int J Radiat Oncol Biol Phys. 2024;118(4):1094\u2013104.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3666_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nprot.2017.136","volume":"13","author":"J Roper","year":"2018","unstructured":"Roper J, et al. Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation. Nat Protoc. 2018;13(2):217\u201334.","journal-title":"Nat Protoc"},{"issue":"1","key":"3666_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12022-025-09854-3","volume":"36","author":"M Schmitt","year":"2025","unstructured":"Schmitt M, et al. DLL3 expression in neuroendocrine carcinomas and neuroendocrine tumours: insights from a multicentric cohort of 1294 pulmonary and extrapulmonary neuroendocrine neoplasms. Endocr Pathol. 2025;36(1):9.","journal-title":"Endocr Pathol"},{"issue":"5","key":"3666_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/2056-4538.12394","volume":"10","author":"S Foersch","year":"2024","unstructured":"Foersch S, et al. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis. J Pathol Clin Res. 2024;10(5):e12394.","journal-title":"J Pathol Clin Res"},{"issue":"4","key":"3666_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100442","volume":"37","author":"A Grass","year":"2024","unstructured":"Grass A, et al. PITX2 as a sensitive and specific marker of midgut neuroendocrine tumors: results from a cohort of 1157 primary neuroendocrine neoplasms. Mod Pathol. 2024;37(4):100442.","journal-title":"Mod Pathol"},{"issue":"3","key":"3666_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.5375","volume":"250","author":"N Singh","year":"2020","unstructured":"Singh N, et al. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol. 2020;250(3):336\u201345.","journal-title":"J Pathol"},{"key":"3666_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep25533","volume":"6","author":"S Parekh","year":"2016","unstructured":"Parekh S, et al. The impact of amplification on differential expression analyses by RNA-seq. Sci Rep. 2016;6:25533.","journal-title":"Sci Rep"},{"issue":"4","key":"3666_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/gcc.22431","volume":"56","author":"N Pfarr","year":"2017","unstructured":"Pfarr N, et al. Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance. Genes Chromosomes Cancer. 2017;56(4):255\u201365.","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"3666_CR49","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko EZ, et al. Highly parallel Genome-wide expression profiling of individual cells using nanoliter droplets. Cell. 2015;161(5):1202\u201314.","journal-title":"Cell"},{"issue":"D1","key":"3666_CR50","doi-asserted-by":"publisher","first-page":"D942","DOI":"10.1093\/nar\/gkac1071","volume":"51","author":"A Frankish","year":"2023","unstructured":"Frankish A, et al. GENCODE: reference annotation for the human and mouse genomes in 2023. Nucleic Acids Res. 2023;51(D1):D942\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"3666_CR51","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"3666_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"3666_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, et al. Gene set knowledge discovery with Enrichr. Curr Protoc. 2021;1(3):e90.","journal-title":"Curr Protoc"},{"issue":"3","key":"3666_CR54","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","volume":"1","author":"Z Gu","year":"2022","unstructured":"Gu Z. Complex heatmap visualization. Imeta. 2022;1(3):e43.","journal-title":"Imeta"},{"issue":"D1","key":"3666_CR55","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"3666_CR56","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"14","key":"3666_CR57","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"17","key":"3666_CR58","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","volume":"30","author":"GG Faust","year":"2014","unstructured":"Faust GG, Hall IM. SAMBLASTER: fast duplicate marking and structural variant read extraction. Bioinformatics. 2014;30(17):2503\u20135.","journal-title":"Bioinformatics"},{"issue":"12","key":"3666_CR59","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov A, et al. Sambamba: fast processing of NGS alignment formats. Bioinformatics. 2015;31(12):2032\u20134.","journal-title":"Bioinformatics"},{"issue":"4","key":"3666_CR60","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, et al. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 2016;12(4):e1004873.","journal-title":"PLoS Comput Biol"},{"issue":"16","key":"3666_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"3666_CR62","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes SA, et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43(Database issue):D805\u201311.","journal-title":"Nucleic Acids Res"},{"issue":"7809","key":"3666_CR63","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","journal-title":"Nature"},{"issue":"6","key":"3666_CR64","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jmoldx.2013.06.002","volume":"15","author":"V Endris","year":"2013","unstructured":"Endris V, et al. Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing. J Mol Diagn. 2013;15(6):765\u201375.","journal-title":"J Mol Diagn"},{"issue":"22","key":"3666_CR65","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, et al. A National cancer Institute workshop on microsatellite instability for cancer detection and Familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248\u201357.","journal-title":"Cancer Res"},{"issue":"12","key":"3666_CR66","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/labinvest.2008.100","volume":"88","author":"M Bettstetter","year":"2008","unstructured":"Bettstetter M, et al. MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples. Lab Invest. 2008;88(12):1367\u201375.","journal-title":"Lab Invest"},{"key":"3666_CR67","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-2407-14-121","volume":"14","author":"B Orsetti","year":"2014","unstructured":"Orsetti B, et al. Impact of chromosomal instability on colorectal cancer progression and outcome. BMC Cancer. 2014;14:121.","journal-title":"BMC Cancer"},{"key":"3666_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021738","author":"J Debattista","year":"2023","unstructured":"Debattista J, et al. Copy number variations as determinants of colorectal tumor progression in liquid biopsies. Int J Mol Sci. 2023;24(2). https:\/\/doi.org\/10.3390\/ijms24021738.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3666_CR69","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nm.2695","volume":"18","author":"S Yui","year":"2012","unstructured":"Yui S, et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell. Nat Med. 2012;18(4):618\u201323.","journal-title":"Nat Med"},{"issue":"9","key":"3666_CR70","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41416-019-0722-0","volume":"122","author":"EP Allain","year":"2020","unstructured":"Allain EP, et al. Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression. Br J Cancer. 2020;122(9):1277\u201387.","journal-title":"Br J Cancer"},{"issue":"2","key":"3666_CR71","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s12029-023-01004-4","volume":"55","author":"T Pancsa","year":"2024","unstructured":"Pancsa T, et al. POLE-Mutant colon Adenocarcinoma-Case presentation and histopathological evaluation. J Gastrointest Cancer. 2024;55(2):961\u20134.","journal-title":"J Gastrointest Cancer"},{"issue":"5","key":"3666_CR72","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/modpathol.2016.54","volume":"29","author":"K Friedman","year":"2016","unstructured":"Friedman K, et al. Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Mod Pathol. 2016;29(5):528\u201341.","journal-title":"Mod Pathol"},{"issue":"9","key":"3666_CR73","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/modpathol.2016.95","volume":"29","author":"MW Rosenbaum","year":"2016","unstructured":"Rosenbaum MW, et al. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes. Mod Pathol. 2016;29(9):1104\u201312.","journal-title":"Mod Pathol"},{"key":"3666_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01744","volume":"10","author":"L Therachiyil","year":"2020","unstructured":"Therachiyil L, et al. Dysregulated phosphorylation of p53, autophagy and stemness attributes the mutant p53 harboring colon cancer cells impaired sensitivity to oxaliplatin. Front Oncol. 2020;10:1744.","journal-title":"Front Oncol"},{"issue":"24","key":"3666_CR75","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1080\/15384101.2019.1688951","volume":"18","author":"Y Huang","year":"2019","unstructured":"Huang Y, et al. Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA. Cell Cycle. 2019;18(24):3442\u201355.","journal-title":"Cell Cycle"},{"issue":"4","key":"3666_CR76","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ejso.2020.09.017","volume":"47","author":"RA Nagourney","year":"2021","unstructured":"Nagourney RA, et al. Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. Eur J Surg Oncol. 2021;47(4):738\u201342.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"3666_CR77","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00428-024-03746-3","volume":"484","author":"PD Dunne","year":"2024","unstructured":"Dunne PD, Arends MJ. Molecular pathological classification of colorectal cancer-an update. Virchows Arch. 2024;484(2):273\u201385.","journal-title":"Virchows Arch"},{"issue":"5","key":"3666_CR78","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.3174","volume":"19","author":"EMF De Sousa","year":"2013","unstructured":"De Sousa EMF, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med. 2013;19(5):614\u20138.","journal-title":"Nat Med"},{"key":"3666_CR79","doi-asserted-by":"crossref","unstructured":"Cascianelli S, et al. Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity. Genome Med. 2023;15(1):37.","DOI":"10.1186\/s13073-023-01176-5"},{"key":"3666_CR80","unstructured":"Avolio M, et al. The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancer. Cancer Discov. 2025."},{"key":"3666_CR81","doi-asserted-by":"crossref","unstructured":"Leto SM, et al. XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients. Nat Commun. 2024;15(1):7495.","DOI":"10.1038\/s41467-024-51909-2"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03666-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:50:02Z","timestamp":1781635802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03666-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3666"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03666-x","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the ethics committee vote 458\/17 S (Amendment: 256\/18 S) of the TUM University Hospital of the Technical University of Munich.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}